Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

NCT01098240 ·Status: TERMINATED ·Phase: PHASE2

Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder

NCT01733654 ·Status: WITHDRAWN ·Phase: PHASE2

A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression

NCT00250653 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication

NCT04937829 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

NCT06254612 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

NCT01724112 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder

NCT02902601 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test Different Doses of BI 1569912 in People With Depression

NCT06558344 ·Status: COMPLETED ·Phase: PHASE2

Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects

NCT00949767 ·Status: COMPLETED ·Phase: PHASE1

Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)

NCT00610649 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)

NCT05081167 ·Status: COMPLETED ·Phase: PHASE3

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

NCT00250601 ·Status: COMPLETED ·Phase: PHASE3

Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer

NCT05947383 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

NCT00731653 ·Status: COMPLETED ·Phase: PHASE2

A Study of Psilocybin for Major Depressive Disorder (MDD)

NCT03866174 ·Status: COMPLETED ·Phase: PHASE2

Psilocybin for Major Depressive Disorder (MDD)

NCT06308653 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density

NCT04630964 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

NCT05203341 ·Status: COMPLETED ·Phase: PHASE2

Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients

NCT02529462 ·Status: COMPLETED ·Phase: PHASE3

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

NCT07226661 ·Status: RECRUITING ·Phase: PHASE2

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

NCT05518149 ·Status: TERMINATED ·Phase: PHASE3

Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

NCT05536414 ·Status: COMPLETED ·Phase: PHASE2

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

NCT06785012 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

NCT00252330 ·Status: COMPLETED ·Phase: PHASE3

SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study

NCT01436175 ·Status: TERMINATED ·Phase: PHASE3